Haemophilus test medium (HTM) was developed recently for dilution and disk diffusion antimicrobial agent susceptibility testing of Haemophilus influenza. The application of HTM to the testing of other, less frequently encountered Haemophilus species recovered from humans was evaluated in this study by using commercially prepared HTM (BBL Microbiology Systems, Cockeysville, Md.) in broth microdilution and agar disk diffusion susceptibility tests with 18 antimicrobial agents. A total of 93.3% of 90 isolates belonging to six Haemophilus species provided acceptable growth in HTM agar disk diffusion tests, while only 63.3% (57 of 90) provided acceptable growth in the broth microdilution tests. However, HTM agar dilution testing provided an alternative method for those strains (primarily H. haemolyticus) which failed to grow adequately in broth. Based on the latest National Committee for Clinical Laboratory Standards guidelines (standard M2-T4) for interpretation of HTM disk tests of H. influenza, the overall very major, major, and minor errors for all 18 drugs and six species tested were 0.2, 0.7, and 3.4%, respectively. Thus, the use of HTM in agar or broth susceptibility tests can be recommended for testing the less commonly encountered Haemophilus species by using the same test conditions and interpretive guidelines developed for H. influenzae.
Haemophilus test medium (HTM) was developed recently for dilution and disk diffusion antimicrobial agent susceptibility testing of Haemophilus influenza. The application of HTM to the testing of other, less frequently encountered Haemophilus species recovered from humans was evaluated in this study by using commercially prepared HTM (BBL Microbiology Systems, Cockeysville, Md.) in broth microdilution and agar disk diffusion susceptibility tests with 18 antimicrobial agents. A total of 93.3% of 90 isolates belonging to six Haemophilus species provided acceptable growth in HTM agar disk diffusion tests, while only 63.3% (57 of 90) provided acceptable growth in the broth microdilution tests. However, HTM agar dilution testing provided an alternative method for those strains (primarily H. haemolyticus) which failed to grow adequately in broth. Based on the latest National Committee for Clinical Laboratory Standards guidelines (standard M2-T4) for interpretation of HTM disk tests of H. influenza, the overall very major, major, and minor errors for all 18 drugs and six species tested were 0.2, 0.7, and 3.4%, respectively. Thus, the use of HTM in agar or broth susceptibility tests can be recommended for testing the less commonly encountered Haemophilus species by using the same test conditions and interpretive guidelines developed for H. influenzae.
Recently, a new medium, Haemophilus test medium (HTM) (6), has been recommended by the National Committee for Clinical Laboratory Standards (NCCLS) for dilution and disk diffusion testing of Haemophilus influenza (9, 10). The MIC and zone size interpretive criteria advocated by the NCCLS for this new medium apply specifically to H. influenzae. A number of other Haemophilus species are prominent members of the human oral microflora but also cause occasional cases of infective endocarditis or osteomyelitis or infections of other normally sterile body cavities (1-4, 7, 11, 12) . The purpose of this study was to determine whether HTM can be used for antimicrobial agent susceptibility testing of clinically significant isolates of these less frequently encountered Haemophilus species and whether the NCCLS interpretive criteria (9, 10) can be uniformly applied to the results of such tests. at 35°C in 5% C02 was adjusted photometrically to the turbidity of a no. 0.5 McFarland standard. This suspension was further diluted to achieve an inoculum of 5 x 105 CFU/ml in the microdilution tray wells. Following incubation at 35°C for 20 to 24 h in ambient air, MIC endpoints were determined and recorded.
MATERIALS AND METHODS
HTM agar dilution tests. HTM agar was prepared as described previously (6) by using Mueller-Hinton agar base (BBL) supplemented with 15 ,ug of bovine hematin (Sigma Chemical Co., St. Louis, Mo.) per ml, 15 ,ug of P-NAD (Sigma) per ml, and 5 mg of yeast extract (BBL) per ml. A 30-ml portion of hematin stock solution and 5 g of yeast extract were added to 1 liter of dissolved Mueller-Hinton agar base before autoclaving. A fresh hematin stock solution was prepared by dissolving 50 mg of bovine hematin (Sigma) in 100 ml of 0.01 N NaOH with gentle heat and stirring for 20 to 30 min or until the powder was completely dissolved. After autoclaving and cooling, 3 ml of NAD stock solution was added aseptically. The NAD stock solution was made by dissolving 50 mg of NAD in 10 ml of distilled water, followed by filter sterilization using a membrane filter (pore size, 0.22 ,um). Twofold concentration increments of the various antimicrobial agents were incorporated into the molten HTM agar, and the preparations were dispensed into plastic petri plates (diameter, 100 mm). The inoculum suspensions were adjusted to the density of a no. 0. The photometrically adjusted suspensions were used to swab the surfaces of the HTM agar plates in the usual manner; this was followed by application of up to nine The HTM-derived MICs (whether determined by broth-or agar-based tests) for all six species tested were plotted versus their disk diffusion zone diameters for the 18 antimicrobial agents included in the study. Figure 1 shows selected scattergrams for data from all six species combined. The current NCCLS interpretive breakpoints (indicated on Fig.  1 ) allowed appropriate classification of susceptibility and resistance in the majority of strains. Table 2 (Fig. 1D) . Likewise, the highest single category of major errors occurred with ceftazidime (8.3%). Very major and major errors incurred with the other drugs were quite low. Overall, there were 0.2% very major, 0.7% major, and 3.4% minor errors for the 18 drugs and six Haemophilus species tested. All ampicillin-resistant (P-lactamase-producing), chloramphenicol-resistant (CAT-producing), and tetracycline-resistant strains were correctly classified by the HTMbased tests. DISCUSSION Haemophilus species (other than H. influenza) are occasionally the causes of endocarditis, bacteremia, osteomyelitis, and other infectious processes arising from an oropharyngeal source (1-4, 7, 11, 12) . Clinical microbiology laboratories may find it necessary to perform antimicrobial agent susceptibility tests on such isolates when their clinical significance appears likely. Relatively little guidance is available from sources such as the NCCLS regarding the appropriate methodology for susceptibility testing of unusual, fastidious, gram-negative bacteria.
HTM has been recommended recently by the NCCLS for either dilution or disk diffusion susceptibility testing of H. influenza (9, 10) . MIC and zone size interpretive criteria for H. influenzae are now available for 18 different antimicrobial agents when they are tested by using HTM. An H. influenza quality control strain (ATCC 49247) has also been selected, and control ranges have been developed specifically for HTM (NCCLS documents M2-A4 and M7-A2, in press). It is possible that the enhanced nutritive properties of HTM might allow it to be used for testing of other fastidious bacteria. We have shown recently that HTM supports the growth of pneumococci and that susceptibility results determined in HTM agree closely with results of pneumococcal tests performed by using lysed horse blood-supplemented Mueller-Hinton broth (J. H. Jorgensen 
